April 23, 2010 - Clinical study demonstrates that Cardiola’s m.pulse® system “immediately improves cardiac output under acute non-invasive Muscular CounterPulsation (MCP) treatment in patients with patients with stable CHF” (chronic heart failure) - Data presented at annual congress of the German Society of Cardiology — Cardiola AG announced that the Company’s CE-Marked m.pulse® Muscular CounterPulsation (“MCP”)-based system demonstrated “an immediate improvement of cardiac output with non-invasive means” in a patient population of advanced yet stable chronic heart failure. The effects could be shown in 22 patients over three consecutive days.... [PDF] Cardiola's Press Release -
Tuesday, June 1, 2010
Cardiola : m.pulse® system “immediately improves cardiac output under acute non-invasive Muscular CounterPulsation (MCP) treatment in patients with...
April 23, 2010 - Clinical study demonstrates that Cardiola’s m.pulse® system “immediately improves cardiac output under acute non-invasive Muscular CounterPulsation (MCP) treatment in patients with patients with stable CHF” (chronic heart failure) - Data presented at annual congress of the German Society of Cardiology — Cardiola AG announced that the Company’s CE-Marked m.pulse® Muscular CounterPulsation (“MCP”)-based system demonstrated “an immediate improvement of cardiac output with non-invasive means” in a patient population of advanced yet stable chronic heart failure. The effects could be shown in 22 patients over three consecutive days.... [PDF] Cardiola's Press Release -
